The outcome of patients with uterine carcinosarcoma

Simple item page
dc.contributor.authorMbodi, Langanani
dc.date.accessioned2020-03-11T13:17:34Z
dc.date.available2020-03-11T13:17:34Z
dc.date.issued2018-11-14
dc.descriptionA research report for the fulfillment of the requirement by the MSc (Research) degree of the University of Witwatersrand, 2018en_ZA
dc.description.abstractObjectives. The study aimed to determine the outcome of women with uterine carcinosarcoma and treated with surgery alone, surgery and adjuvant irradiation or surgery and adjuvant chemotherapy at Charlotte Maxeke Johannesburg Academic hospital (CMJAH). Methods. Women with a histologically confirmed diagnosis of uterine carcinosarcoma managed with the three modalities at CMJAH were selected retrospectively over 10 years. Survival graphs were generated using the Kaplan-Meier method. Results. A total of 32 women met the inclusion criteria for the study. The mean age was 63.34 years (SD±8.65). Total Abdominal Hysterectomy (TAH) & Bilateral Salpingo- Oophorectomy (BSO) was done in 12 (37.50%), TAH/BSO/Washings in 7 (21.88%), TAH /BSO/Omentectomy in 4 (12.50%), TAH/BSO/Washings and Omentectomy in 4 (12.50%) and TAH/BSO/Lymphadenectomy (LND) & Washings in 2 (6.25%) women. There was no statistical association between survival after treatment and uterine size (p=0.638), ECOG status (p=0.571), lymphovascular invasion (p=0.687), treatment with radiotherapy (p=0.202) and recurrence period of disease. The mean survival from surgery was 15.5 months (SD± 88.79) and 11.25 months (SD±66.47) in radiotherapy group. Survival estimates calculations on chemotherapy group were difficult due to small sample. Conclusion. Treatment with radiotherapy or chemotherapy after surgery offers no survival benefit. However, this was a low powered study. The role of nuclear medicine modalities such as Targeted Alpha Therapy (TAT) in carcinosarcoma has not been well explored and perhaps it may offer better outcome.en_ZA
dc.description.librarianMN2020en_ZA
dc.facultyFaculty of Health Sciencesen_ZA
dc.format.extentOnline resource (50 leaves)
dc.identifier.citationMbodi, Langanani (2018) The outcome of patients with Uterine Carcinosarcoma, University of the Witwatersrand, Johannesburg, <http://hdl.handle.net/10539/29124>
dc.identifier.urihttps://hdl.handle.net/10539/29124
dc.language.isoenen_ZA
dc.schoolSchool of Public Healthen_ZA
dc.subject.meshGenitalia, female
dc.subject.meshGenital Neoplasms, Female
dc.titleThe outcome of patients with uterine carcinosarcomaen_ZA
dc.typeThesisen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
THE OUTCOME OF PATIENTS WITH UTERINE CARCINOSARCOMA_Final post examiners_22_10_2018_3.pdf
Size:
691.96 KB
Format:
Adobe Portable Document Format
Description:
Main work
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
ETD Collection